Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Opis bibliograficzny
Główni autorzy:	Lei, M, Wu, L, Terrar, D, Huang, C
Format:	Journal article
Język:	English
Wydane:	American Heart Association 2019

Podobne zapisy

Letter to the editor regarding the article of Chen et al.
od: Mehmet Sami Islamoglu, i wsp.
Wydane: (2022-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
od: Joanne J. A. van Bavel, i wsp.
Wydane: (2018-02-01)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
od: Keitaro Hashimoto
Wydane: (2007-01-01)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
od: Antoniades, C, i wsp.
Wydane: (2010)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
od: Rider, O, i wsp.
Wydane: (2013)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
od: T. N. Lipnitsky, i wsp.
Wydane: (2007-12-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
od: T. N. Lipnitsky, i wsp.
Wydane: (2007-12-01)

Modernised classification of cardiac anti-arrhytmic drugs
od: Lei, M, i wsp.
Wydane: (2018)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
od: Peterzan, MA, i wsp.
Wydane: (2020)

Letter to the Editor Regarding Vaping Article
od: Rabbi Yehuda Spitz
Wydane: (2019-10-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
od: Sutanto, H, i wsp.
Wydane: (2019)

A Letter to the Editor on the Article by Farnam et al
od: Anne Rutte, MSc, i wsp.
Wydane: (2015-06-01)

Interactions that matter: 10 Antiarrhythmic drugs
od: Aronson, J
Wydane: (1987)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
od: Antoniades, C, i wsp.
Wydane: (2005)

Letter to the Editor regarding Cunningham et al. 2020
Wydane: (2021-04-01)

Effects of Antiarrhythmic Drugs on Apoptotic Pathways in H9c2 Cardiac Cells
od: Shojiro Isomoto, i wsp.
Wydane: (2006-01-01)

A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs
od: Ahmad Beik, i wsp.
Wydane: (2020-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
od: A. A. Upnitskiy
Wydane: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
od: Nathalie Oeffl, i wsp.
Wydane: (2023-05-01)

Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
od: Santiago Rodríguez Villafuerte, i wsp.
Wydane: (2025-01-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
od: Farnam Farnaz, PhD, i wsp.
Wydane: (2015-09-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
od: IRAJ NAZERY , i wsp.
Wydane: (1986-12-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
od: IRAJ NAZERY, i wsp.
Wydane: (1986-05-01)

Letter to the Editor regarding article Health effects of voluntary exposure to cold water – a continuing subject of debate, by Espeland, et al
od: Richard A. Reinhart
Wydane: (2023-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
od: V. L. Doshchitsin, i wsp.
Wydane: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
od: B. A. Tatarsky, i wsp.
Wydane: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
od: Marco Valerio Mariani, i wsp.
Wydane: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
od: Sean P. Gaine, i wsp.
Wydane: (2023-04-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
od: Gheorghe-Andrei Dan, i wsp.
Wydane: (2018-12-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
od: Ibrahim El-Battrawy, i wsp.
Wydane: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
od: Ravshanbek D. Kurbanov, i wsp.
Wydane: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
od: Koichiro Kumagai, MD, i wsp.
Wydane: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
od: Xu Gao, i wsp.
Wydane: (2018-03-01)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
od: A. D. Krieg, i wsp.
Wydane: (2021-11-01)

Response to letter by Campbell et al. regarding the results of the COSTICK trial
od: Andrew Smyth, i wsp.
Wydane: (2023-07-01)

Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
od: Johnna Perdrizet, i wsp.
Wydane: (2022-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
od: K. A. Skiba, i wsp.
Wydane: (2003-06-01)

A letter to the editor regarding the original article by Costa et al: Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria
od: Biggs, M
Wydane: (2019)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
od: Fenglin Jiang
Wydane: (2021-07-01)

Response by Shimura et al. to the letter regarding article “Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement”
od: Tetsuro Shimura, i wsp.
Wydane: (2021-08-01)